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Abstract
Background: Due to the lack of clear, comprehensive, and rational drug policy, the production of pharmaceutical
preparations in India is distorted for the most part. Indian markets are flooded with more than 70,000 formulations,
compared to approximately 350 formulations listed in the World Health Organization (WHO) Essential Drug List.
Studies have indicated that majority of prescriptions in India are of drugs of “doubtful efficacy.” To promote rational
drug use in developing countries, assessment of drug use patterns with the WHO drug use indicators is becoming
increasingly necessary. The aim of this study was to assess the patterns of drug use by using WHO core drug use
and complementary indicators.
Methods: One thousand fifty-two patients were prospectively interviewed and their prescriptions analyzed according
to WHO guideline five randomly selected busy community pharmacies in northern district of the State of Tamil Nadu,
South India to analyze the WHO core drug use and complementary indicators using an investigator-administered data
collection form. The main outcome measured is patterns of drug use measured using WHO core drug use and
complementary indicators.
Results: The data obtained showed that, out of total drugs prescribed (3936), only 2.5 % (100) drugs were prescribed
by generic name. Mean number of drugs per encounter was 3.7. Use of antibiotics was 22 %, percentage of
encounters with an injection was 7.2 %, and the percentage of drugs prescribed from formulary was 99.8 %.
Conclusions: Brand name prescribing is dominated even in rural India. There is a need to improve the availability of
essential guidelines and key drugs in the stock in rural areas of India. Prescriptions studied were conforming to most
indicators of WHO except the number of drugs prescribed & generic name prescription practice, which deviated. In
India the healthcare is dominated by private practitioners at the primary level. Prescription practices of the individual
community-based clinician needs consistent monitoring with respect to generic name prescribing habits as well as the
number of drugs prescribed. The WHO drug use indicator guidelines need to be promoted amidst the primary care
clinicians and should not be just limited to hospitals having a formulary. The data collected by this study can be used by
policymakers to monitor and improve the prescribing and consumption of pharmaceutical products in Southern India.
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Background
World Health Organization (WHO) defined rational use
of drugs as “patients receive medicines appropriate to
their clinical needs, in doses that meet their own individ-
ual requirements for an adequate period of time, at the
lowest cost to them and their community [1].” Due to the
lack of clear, comprehensive, and rational drug policy, the
production of pharmaceutical preparations in India is
distorted for the most part. Indian markets are flooded
with more than 70,000 formulations. Thousands of drug
companies operate in India and they manufacture generic
preparations with different brand names. Huge number of
vitamins, tonics, and multi-drug combinations that are
unique to Indian market are also manufactured and mar-
keted here. This entails the drug manufacturers to enter
into fierce competition, which makes them to encourage
the prescribers to prescribe branded medicines, often in
exchange of small favor. This benefits the manufacturing
companies, but it also results in drugs being prescribed
without any necessity and combinations that are not
rational [2, 3]. A concerted effort is needed to readjust
pharmaceutical actions and practices aiming at the
rational use of medications. WHO developed Medication
Use Indicators, including Prescription Indicators with an
aim to evaluate the services provided to the population in
regards to medications [4]. Prescription Indicators allow
the therapeutic actions taken in similar institutions to be
ascertained, enabling subsequent comparison of parame-
ters between them, and to evaluate the population’s
medication needs and determine the most frequently used
medications in a given place [4]. In addition, these indica-
tors enable the investigator to identify the prescription
profile and quality of services offered to the population.
The prescription Indicators are as follows [4]:
Average number of drugs per medical prescription
This indicator helps in investigating poly-medication,
which is a major factor contributing to adverse drug
reactions (ADRs) and drug-drug interactions (DDIs).
The educational quality informational level of the pre-
scriber may also be observed [4].
Percentage of drugs prescribed by generic name
This indicator enables the investigator to calculate the
number of prescriptions in which the drugs are pre-
scribed by the generic name. This helps in controlling
drug costs in the health service. It also evaluates the
marketing influence on the person prescribing drugs [4].
Percentage of drugs prescribed from essential drug list or
formulary
This indicator helps in measuring the degree to which
practices conform to the current National Drug Policy
(NDP) of October 1998. By following essential drug list,
it guarantees the treatment of the principal diseases of the
population besides controlling overall cost of medications.
Percentage of encounters with an antibiotic prescribed
This indicator evaluates the use of antibiotics in
excess which contributes to bacterial dissemination
and resistance [4].
Percentage of prescribed injectable drugs
This indicator helps to evaluate the injectables in excess,
administration of which may have serious consequences
when prescribed or applied wrongly, such as in the event
of anaphylactic reactions, adverse reactions, necrosis,
etc. [4]. Even though, this indicator helps in evaluation
of attention given to health swiftly, these indicators do
not quantify all the important aspects of drug use [4].
Studies have indicated that majority of prescriptions in
India are of drugs of “doubtful efficacy” [5–7]. Due to high
cost of inappropriate use of drugs, developing countries
face more problems due to limited economic resources
and lack of organized drug policy [8]. To promote rational
drug use in developing countries, assessment of drug use
patterns with the WHO drug use indicators is becoming
increasingly necessary [9, 10].
The current status of drug use pattern in South India
All evidences available indicate that observations have
been made only in hospitals and not in the private
clinics that cater to the majority of the population in this
part of the country. Even those observations reveal that
the prescription pattern is not in line with the WHO
drug use guidelines. Though there is a guideline stating
that the durgs should be prescribed using the generic
names, adherence to that can hardly be observed across
this subcontinent [6, 7].
Aim of the study
To assess the patterns of drug use by using WHO pre-
scribing, health facility, and complementary indicators in
selected community pharmacies in Southern India.
Methods
Study design
A prospective, cross-sectional survey was carried out in
five randomly selected busy community pharmacies
from different cities in a northern district of State of
Tamil Nadu, South India. The study was conducted
between June 2014 and May 2015 in order to consider
the prescriptions that flow through all seasonal periods.
The study sample comprised of all the medication pre-
scriptions made out of those five selected pharmacies.
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Data collection
Two well-trained clinical pharmacists collected data on
prescribing, health facility, and complementary indicators
by observing the prescriptions and interviewing the
patients. A data collection form prepared exclusively for
this study was used to collect data. Information obtained
included prescribing date, gender identity, age, and BMI of
the patients, educational qualification of patients, physician
specialty, prescription-related information such as dosage
forms and the number of medicines per prescription, and
WHO core drug prescription indicators and complemen-
tary indicators. According to a document by WHO “How
to investigate drug use in health facilities,” at least 600 pre-
scription encounters should be included in cross-sectional
survey to describe the current prescription pattern [10].
The sample selected was by systematic random sampling
method. The sampling unit was patient encounters taking
place at selected five community pharmacies.
Prescribing indicators measurement
The WHO prescribing indicators were pretested and
slight modification was made to make it applicable in
Indian scenario before using in this study. The formula
adopted from the WHO’s manual for the assessment
prescribing indicators used in this study are as follows:
1. Average number of drugs per encounter = Total
number of drugs prescribed/Total number of
encounters sampled. (Combinations of drugs
prescribed for one health problem were counted
as one.
2. Percentage of drugs prescribed by generic name
= (Number of drugs prescribed by generic name/
Total number of drugs prescribed) × 100.
3. Percentage of encounters with an antibiotic prescribed
= (Number of patient encounters with an antibiotic/
Total number of encounters sampled) × 100.
4. Percentage of encounters with an injection
prescribed = (Number of patient encounters with an
injection prescribed/Total number of encounters
sampled) × 100.
5. Percentage of drugs prescribed from essential drugs
list = (Number of drugs prescribed from essential
drugs list/Total number of prescribed drugs) × 100.
Patient care indicators measurement
Patient care indicators measured were consultation time,
dispensing time, and percentage of drugs actually dis-
pensed. Consultation and dispensing times were divided
in three categories viz., ≤ 5 min, 6–10 min, and 11–15
min. Percentage of drugs actually dispensed was calcu-
lated by dividing the number of drugs actually dispensed
at each of the community pharmacy by the total number
of drugs prescribed multiplied by 100.
Health facility indicators measurement
Health facility indicators measured were drugs available
in the formulary and drugs not available in formulary.
It can be measured by subtracting drugs not available
in the formulation from total amount of drugs pre-
scribed × 100.
Complementary indicators measurement
Complementary indicators analyzed were number of
patients treated without drug, number of patient treated
with drugs, cost of injections prescribed, and the ratio of
drugs prescribed versus drugs dispensed. These were
expressed in percentage.
Data analysis
All data in the data collection form were analyzed using
Microsoft Excel 2007. The indicators are reported as
means and proportions. From five community pharmacies
218, 215, 197, 220 and 202 prescriptions were analyzed
respectively.
Results
Out of 1052 patient encounters assessed during the
study period, 447 (42.5 %) were males and 605 (57.5 %)
were females with a mean age of 28.37 years. The classi-
fication of patient encounters based on BMI shows that
most of the patients fell in the overweight BMI range 25
to 29.9 (35.4 %) followed by normal BMI range of 18.5
to 24.9 (32.8 %). The educational status of the patient
encounters reveals that 40.2 % of the patients (N = 423)
have finished at least undergraduate studies. This is
shown in Table 1.
Highest number of prescriptions encountered were
from consultant physicians (N = 271, 25.8 %) followed by
the pediatricians (N = 205, 19.5 %), general practitioner
(N = 180, 17.1 %), gynecologist (N = 139, 13.2 %)
followed by ENT, orthopedic, and the dentist (N = 119,
78, and 41; 11.3, 7.4 and 3.9 % respectively). The derma-
tologists and the civil surgeons contributed together to
12.5 % of prescriptions in total. The consultant physician
was the first choice for the patients as majority of the
prescriptions encountered were that of adults, followed
by the pediatrician and the general practitioner. The civil
surgeon was the last choice for the patients. We could also
see from the prescriptions that the non-pediatric patients
were also treated by the pediatrician. The indication wise
distribution of data shows that up to 40 % of the total
prescriptions were given for indications like cough/cold/
congestion/fever/headache. Acute infections and the
allergic reactions were the major cause for the patients
to come to the clinics. This can be shown in Table 2.
The distribution of drug prescription indicators shows
that more than 53.2 % of the encounters contained four
drugs with an average number of drugs per encounter of
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3.7, which should always be maintained as low as
possible to reduce adverse effect and patient medication
cost. Almost 92 % of the prescription encounters con-
tained no drugs prescribed by their generic names and
about 58.8 % of prescriptions contained at least one
antibiotic and 24.3 % contained at least one injection.
Surprisingly, all the drugs dispensed through those 1052
prescriptions were present in essential drug list. The
community pharmacies ensure that any prescription is
dispensed in full. In the rural areas, when a patient
returns with an incompletely filled prescription, he may
not return to the pharmacy for any future need as he/she
may perceive the pharmacy as one that’s inadequately
stocked. At least the community pharmacy owners and
the counter managers or the pharmacists ensure that the
generic equivalent, whether it is bio-equivalent or not, is
substituted for what is prescribed by the physician. So, the
availability of drugs from the formulary was 100 %. This
can be clearly seen in Table 3.
The patient care indicators consisted of three compo-
nents such as consultation time, dispensing time and
percentage of drug actually dispensed. Maximum num-
ber of patients (N = 822, 78.1 %), had anywhere between
the 6–10 min of consulting time with a physician with
an average time of 8 min. The dispensing time required
for 82.5 % of the prescription encounters fell between 6
and 10 min range. The dispensing time taken in rural
areas was low when compared to another department of
other hospital because prescription consists mainly
Table 1 Socio-demographic characteristics of patients served in
five community pharmacies in Southern India










































































SSLC secondary school leaving certificate, HSC higher secondary certificate, UG
under graduate, PG post graduate
Table 2 Distribution of physician specialty and indications of
prescription encounters




































































aAnemia Burns/injury Eye infection Wounds
Table 3 Distribution of drug prescription indicators in five
community pharmacies in Southern India


















































Number of drugs prescribed from
essential drug list
1052 100
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tablets and capsules, which are prescribed in different
doses, but at regular intervals. So, pharmacists required
less time for the dispensing. In 1052 prescriptions, 3936
drugs were prescribed and the percentage of actual drug
dispensed was 99.8 %. This is depicted in Table 4.
A total of 3936 drugs were prescribed from 1052 pre-
scription encounters, in which, 3927 drugs was available
in the formulary. 99.8 % of drugs prescribed were dis-
pensed by the community pharmacies. The formulary
concept is totally alien to the community pharmacies
and is not even followed in many hospitals here. But, for
a reference, the prescriptions were catered from the
available stock and so we mean the stock of the individ-
ual retailer as the formulary – the retailers know about
the prescription habits of the physicians in the vicinity
and so they could cater to all prescribed brands or its
generic substitutes. The data obtained also shows that all
patients were treated with drugs and no patient was
treated without a drug. We also analyzed injection drug
cost per prescription as a complementary indicator. The
data obtained shows that most of the injections pre-
scribed (N = 195, 80.2 %) fell in the cost range of below
Rs. 25. The details of health facility indicator and com-
plementary indicator can be seen in Table 5.
Table 6 shows the details of drugs prescribed out
of 1052 prescriptions. A total of 3936 drugs were
prescribed from 1052 prescriptions. Antimicrobials
agents was most commonly prescribed drugs (N = 977,
24.8 %) followed by nutritional supplements (N = 483,
12.3 %), anti-ulcer (N = 470, 11.9 %) anti-allergic (N = 432,
11 %), antipyretic (N = 379, 9.6 %), and antacids & LB
(N = 298, 7.6 %).
Antibiotics are used both as single and as fixed dose
combination and prescribed orally. NSAIDS are also pre-
scribed in tablet form in double dose combination.
Limitations of the study
 Only 1052 prescription encounters were sampled for
this study and a higher number of prescription
encounters are required for better result. This
cannot be generalized to overall prescribing practice
of all private practitioners.
 Prescribing indicators based drug utilization study in
health facilities is not an exhaustive tool to identify
all problems related to prescribing and rationality of
the drug use, as they do not exactly explain why
drugs are prescribed.
 The WHO prescribing indicators measure aspects of
outpatient treatment. They are designed for use in
health centers, dispensaries or hospital outpatient
Table 4 Distribution of patient care indicators in five
community pharmacies in Southern India





















Ratio of drugs prescribed/dispensed 3936/3927 99.8 %
Table 5 Health facility indicator results from five community
pharmacies in Southern India
Indicators Frequency Percentage (%)
Health Facility Indicator (N = 3936)
1. Drugs available in formulary





Complementary Indicator (N = 1052)
1. Number of patients treated
without drug
2. Number of patient treated with drugs














Ratio of drugs dispensed/prescribed 3927/3936 99.8 %
Table 6 Drug class prescribed in five community pharmacies in
Southern India



















aTopical, CNS, Anti-emetic, Anti-amoebic, Laxative, Anti-diarrheal, Urinary
Alkalizer, Musculoskeletal, Enzymes, Antispasmodic drugs
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departments. The prescribing indicators are less
useful in specialty outpatient clinics in referral
hospitals where the drug use pattern is more
complex.
Discussion
In this study, 91.4 % prescriptions did not contain even a
single drug prescribed in its generic name. A similar study
conducted in Goa, the western part of India has similar
observations where only 0.05 % of the drugs out of 1842
products prescribed were in generic name [10]. This study
showed that, in the community pharmacies, where this
study was conducted, most of the indicators analyzed were
in agreement with the WHO’s recommendations, except
for the mean number of drugs per encounter and percent-
age of medications prescribed by generic name which
should be ≤2 and 100 %, respectively [4, 9]. Fixed dose
combinations (FDCs) are one of the strategies to reduce
the number of drugs prescribed and improve medica-
tion compliance. Increasing requirement of drugs in
patients with more than one disease justifies the use
of FDCs [11, 12]. But with the recent ban on 344
FDCs, a question arises on how many prescribed dur-
ing the study were rational? A similar study highlights
the practice of poly-pharmacy, low usage of generic
drugs, injudicious usage of antibiotics and injections
and low usage of drugs from essential drugs list in
other parts of this region in India [13].
Conclusion
The study indicates a clear need for a guideline by the
policy making bodies directing the prescription habits of
all clinicians in this part of India. The rules are defined
and available even today, but the practice is yet to
change is the sad part of the story. Unless strict enforce-
ment of the guidelines happen with consistent monitor-
ing, adherence by clinicians leading to better healthcare
services cannot be guaranteed in this part of India.
Acknowledgement
There was no funding for this study.
Authors’ contributions
All authors contributed equally in design, data collection, data analysis, and
preparation of this manuscript. All authors read and approved the final
manuscript.
Competing interests
The authors declare that they have no competing interests.
Ethics approval and consent to participate
The study was approved by Institutional Ethics Committee in JKK Munirajah
Medical Research Foundation, Kumarapalayam, Tamil Nadu.
Author details
1Department of Pharmacy Practice, JKKMMRFs AJKK SA College of Pharmacy,
Vattamalai, Ethirmedu, B Komarapalayam, Namakkal District 638183,
Tamilnadu, India. 2Department of Pharmacy Practice, RVS College of
Pharmaceutical Sciences, Coimbatore 641402, Tamilnadu, India.
Received: 21 September 2015 Accepted: 23 June 2016
References
1. WHO. The rational use of drugs. Report of a conference of experts, Nairobi,
25–29 November 1985. Geneva: World Health Organization; 1987.
2. Sarkar PK. A rational drug policy. Indian J Med Ethics. 2004;1:11–2.
3. Srinivasan S. A network for the rational and ethical use of drugs. Indian J
Med Ethics. 2004;1:13–4.
4. Vooss AT, Diefenthaeler HS. Evaluation of prescription indicators established
by the WHO in Getulio Vargas - RS. Braz J Pham Sci. 2011;47(2):385–90.
5. Linden M, Lecrubier Y, Bellantuono C, Benkert O, Kisely S, Simon G. The
prescribing of psychotropic drugs by primary care physicians: an
international collaborative study. J Clin Psychopharmacol. 1999;19:132–40.
6. Bhargava A, et al. The crisis in access to essential medicines in India: key
issues which call for action. Indian J Med Ethics. 2013;10(2):86–95.
7. Patel V, et al. Irrational drug use in India: a prescription survey from Goa. J
Postgrad Med. 2005;51(1):9–12.
8. Kshirsagar MJ, Langade D, Patil S, Patki PS. Prescribing patterns among
medical practitioners in Pune, India. Bull World Health Organ. 1998;76:271–5.
9. Hogerzeil HV, Bimo, Ross-Degnan D, Laing RO, Ofori-Adjei D, Santoso B,
Azad Chowdhury AK, Das AM, Kafle KK, Mabadeje AF. Field tests for rational
drug use in twelve developing countries. Lancet. 1993;342(8884):1408–10.
10. Chandelkar UK, Rataboli PV. A study of drug prescribing pattern using WHO
prescribing indicators in the state of Goa, India. Int J Basic Clin Pharmacol.
2014;3(6):1057–61. doi:10.5455/2319-2003.ijbcp20141221.
11. WHO. How to investigate drug use in health facilities: selected drug use
indicators. Geneva: WHO/DAP/93.1; 1993.
12. Vries TP, Henning RH, Hogerzeil H, Fresle DA. WHO Guide to Good
Prescribing. Available at: http://apps.who.int/medicinedocs/pdf/whozip23e/
whozip23e.pdf.
13. Gopalakrishnan S, Ganeshkumar P, Katta A. Assessment of prescribing
practices among urban and rural general practitioners in Tamil Nadu. Indian
J Pharmacol. 2013;45(3):252–7. doi:10.4103/0253-7613.111931. PMCID:
PMC3696296.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Aravamuthan et al. Journal of Pharmaceutical Policy and Practice  (2017) 10:1 Page 6 of 6
